Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children

被引：57

作者：

Tomizawa, D. ^{[1
]}

Tawa, A. ^{[2
]}

Watanabe, T. ^{[3
]}

Saito, A. M. ^{[4
]}

Kudo, K. ^{[5
]}

Taga, T. ^{[6
]}

Iwamoto, S. ^{[7
]}

Shimada, A. ^{[8
]}

Terui, K. ^{[9
]}

Moritake, H. ^{[10
]}

Kinoshita, A. ^{[11
]}

Takahashi, H. ^{[12
]}

Nakayama, H. ^{[13
]}

Koh, K. ^{[14
]}

Kigasawa, H. ^{[15
]}

Kosaka, Y. ^{[16
]}

Miyachi, H. ^{[17
]}

Horibe, K. ^{[4
]}

Nakahata, T. ^{[18
]}

Adachi, S. ^{[19
]}

机构：

[1] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan

[2] Natl Hosp Org, Osaka Med Ctr, Dept Pediat, Osaka, Japan

[3] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Nutr Sci, Nisshin, Japan

[4] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan

[5] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan

[6] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan

[7] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie 514, Japan

[8] Okayama Univ, Dept Pediat, Okayama 7008530, Japan

[9] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan

[10] Miyazaki Univ, Fac Med, Dept Reprod & Dev Med, Div Pediat, Miyazaki, Japan

[11] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan

[12] Saiseikai Yokohama City Southern Hosp, Dept Pediat, Yokohama, Kanagawa, Japan

[13] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Pediat, Koga, Japan

[14] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan

[15] Kanagawa Childrens Med Ctr, Dept Hematol Oncol, Yokohama, Kanagawa, Japan

[16] Hyogo Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan

[17] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 25911, Japan

[18] Kyoto Univ, Ctr IPS Cell Res & Applicat, Kyoto, Japan

[19] Kyoto Univ, Kyoto, Japan

来源：

LEUKEMIA | 2013年 / 27卷 / 12期

关键词：

COOPERATIVE-STUDY-GROUP; HIGH-DOSE CYTARABINE; THERAPY; INTENSIFICATION; FREQUENCY; T(8/21); TRIAL;

D O I：

10.1038/leu.2013.153

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2413 / 2416

页数：5

共 13 条

[1]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[2] Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial [J].

Burnett, Alan K. ;

Hills, Robert K. ;

Milligan, Donald ;

Kjeldsen, Lars ;

Kell, Jonathan ;

Russell, Nigel H. ;

Yin, John A. L. ;

Hunter, Ann ;

Goldstone, Anthony H. ;

Wheatley, Keith .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :369-377

[3] Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study [J].

Castaigne, Sylvie ;

Pautas, Cecile ;

Terre, Christine ;

Raffoux, Emmanuel ;

Bordessoule, Dominique ;

Bastie, Jean-Noel ;

Legrand, Ollivier ;

Thomas, Xavier ;

Turlure, Pascal ;

Reman, Oumedaly ;

de Revel, Thierry ;

Gastaud, Lauris ;

de Gunzburg, Noemie ;

Contentin, Nathalie ;

Henry, Estelle ;

Marolleau, Jean-Pierre ;

Aljijakli, Ahmad ;

Rousselot, Philippe ;

Fenaux, Pierre ;

Preudhomme, Claude ;

Chevret, Sylvie ;

Dombret, Herve .

LANCET, 2012, 379 (9825) :1508-1516

[4] Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16) [J].

Creutzig, Ursula ;

Zimmermann, Martin ;

Bourquin, Jean-Pierre ;

Dworzak, Michael N. ;

von Neuhoff, Christine ;

Sander, Annette ;

Schrauder, Andre ;

Teigler-Schlegel, Andrea ;

Stary, Jan ;

Corbacioglu, Selim ;

Reinhardt, Dirk .

BLOOD, 2011, 118 (20) :5409-5415

[5] Anthracycline Dose Intensification in Acute Myeloid Leukemia [J].

Fernandez, Hugo F. ;

Sun, Zhuoxin ;

Yao, Xiaopan ;

Litzow, Mark R. ;

Luger, Selina M. ;

Paietta, Elisabeth M. ;

Racevskis, Janis ;

Dewald, Gordon W. ;

Ketterling, Rhett P. ;

Bennett, John M. ;

Rowe, Jacob M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1249-1259

[6] Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials [J].

Gibson, BES ;

Wheatley, K ;

Hann, IM ;

Stevens, RF ;

Webb, D ;

Hills, RK ;

De Graaf, SSN ;

Harrison, CJ .

LEUKEMIA, 2005, 19 (12) :2130-2138

[7] Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review [J].

Kremer, LCM ;

van der Pal, HJH ;

Offringa, M ;

van Dalen, EC ;

Voûte, PA .

ANNALS OF ONCOLOGY, 2002, 13 (06) :819-829

[8] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia [J].

Lowenberg, Bob ;

Ossenkoppele, Gert J. ;

van Putten, Wim ;

Schouten, Harry C. ;

Graux, Carlos ;

Ferrant, Augustin ;

Sonneveld, Pieter ;

Maertens, Johan ;

Jongen-Lavrencic, Mojca ;

von Lilienfeld-Toal, Marie ;

Biemond, Bart J. ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

Verdonck, Leo F. ;

Beck, Joachim ;

Doehner, Hartmut ;

Gratwohl, Alois ;

Pabst, Thomas ;

Verhoef, Gregor .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1235-1248

[9] INTENSIVE POSTREMISSION CHEMOTHERAPY IN ADULTS WITH ACUTE MYELOID-LEUKEMIA [J].

MAYER, RJ ;

DAVIS, RB ;

SCHIFFER, CA ;

BERG, DT ;

POWELL, BL ;

SCHULMAN, P ;

OMURA, GA ;

MOORE, JO ;

MCINTYRE, OR ;

FREI, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :896-903

[10] Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial [J].

Rubnitz, Jeffrey E. ;

Inaba, Hiroto ;

Dahl, Gary ;

Ribeiro, Raul C. ;

Bowman, W. Paul ;

Taub, Jeffrey ;

Pounds, Stanley ;

Razzouk, Bassem I. ;

Lacayo, Norman J. ;

Cao, Xueyuan ;

Meshinchi, Soheil ;

Degar, Barbara ;

Airewele, Gladstone ;

Raimondi, Susana C. ;

Onciu, Mihaela ;

Coustan-Smith, Elaine ;

Downing, James R. ;

Leung, Wing ;

Pui, Ching-Hon ;

Campana, Dario .

LANCET ONCOLOGY, 2010, 11 (06) :543-552

← 1 2 →